I agree that this site is using cookies. You can find further informations here.
X
Ørnbjerg, Lykke M
~ 100  results:
Search for persons X
?
1

Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriat..:

Ørnbjerg, Lykke Midtbøll ; Brahe, Cecilie Heegaard ; Linde, Louise...
Joint Bone Spine.  91 (2024)  4 - p. 105729 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Comparing DAPSA, DAPSA28 and DAS28‐CRP in patients with pso..:

Linde, Louise ; Georgiadis, Stylianos ; Ørnbjerg, Lykke M....
Arthritis Care & Research.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Long-term efficacy of a 2-year MRI treat-to-target strategy..:

Møller-Bisgaard, Signe ; Hørslev-Petersen, Kim ; Ørnbjerg, Lykke Midtbøll...
RMD Open.  10 (2024)  1 - p. e003945 , 2024
Link: https://doi.org/10.1136/..
 
?
4

Biological material for biomarker research in spondyloarthr..:

Glintborg, Bente ; Østergaard, Mikkel ; Jørgensen, Jacob Brauner...
Rheumatology.  , 2024
Link: https://doi.org/10.1093/..
 
?
5

Enthesitis in a European registry-based cohort of patients ..:

Mathew, AJ ; Hetland, ML ; Pedersen, MP...
Scandinavian Journal of Rheumatology.  53 (2024)  4 - p. 237-247 , 2024
Link: https://doi.org/10.1080/..
 
?
6

Sex Differences in the Effectiveness of First‐Line Tumor Ne..:

Hellamand, Pasoon ; van de Sande, Marleen G. H. ; Ørnbjerg, Lykke M....
Arthritis & Rheumatology.  76 (2024)  4 - p. 587-598 , 2024
Link: https://doi.org/10.1002/..
 
?
7

Predictors of DAPSA28 remission in patients with psoriatic ..:

Linde, Louise ; Ørnbjerg, Lykke M ; Georgiadis, Stylianos...
https://boris.unibe.ch/183427/.  , 2024
Link: https://boris.unibe.ch/1..
 
?
8

Predictors of DAPSA28 remission in patients with psoriatic ..:

Linde, Louise ; Ørnbjerg, Lykke M ; Georgiadis, Stylianos...
10.1093/rheumatology/kead284.  , 2024
Link: http://hdl.handle.net/10..
 
?
9

Predictors of DAPSA28 remission in patients with psoriatic ..:

Linde, Louise ; Ørnbjerg, Lykke M ; Georgiadis, Stylianos...
https://pure.au.dk/portal/en/publications/0dd5b362-0e5a-4e8f-8245-7ebb1a23e0f2.  , 2024
Link: https://pure.au.dk/porta..
 
?
10

Sex Differences in the Effectiveness of First-Line Tumor Ne..:

Hellamand, Pasoon ; van de Sande, Marleen G.H ; Ørnbjerg, Lykke M...
https://pure.au.dk/portal/en/publications/69a84eee-7d9a-4046-9b05-521f70451a9a.  , 2024
Link: https://pure.au.dk/porta..
 
?
11

Patient-Reported Outcomes (PROs) and PRO Remission Rates in..:

Ørnbjerg, Lykke M ; Rugbjerg, Kathrine ; Georgiadis, Stylianos...
https://pure.au.dk/portal/en/publications/dec609d0-6f0c-4a68-95af-a10be56bd8b4.  , 2024
Link: https://pure.au.dk/porta..
 
?
12

Sex Differences in the Effectiveness of First-Line Tumor Ne..:

Hellamand, Pasoon ; van de Sande, Marleen G.H ; Ørnbjerg, Lykke M...
10.1002/art.42758.  , 2024
Link: http://hdl.handle.net/10..
 
?
13

Commonalities and differences in set-up and data collection..:

Linde, Louise ; Ørnbjerg, Lykke M. ; Rasmussen, Simon H....
Arthritis Research & Therapy.  25 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
14

Corrigendum to 'Predictors of ASDAS-CRP inactive disease in..:

Ørnbjerg, Lykke M. ; Linde, Louise ; Georgiadis, Stylianos...
Seminars in Arthritis and Rheumatism.  58 (2023)  - p. 152141 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Sex differences in the effectiveness of first-line tumour n..:

Hellamand, Pasoon ; van de Sande, Marleen ; Ørnbjerg, Lykke MIdtbøll...
RMD Open.  9 (2023)  4 - p. e003325 , 2023
Link: https://doi.org/10.1136/..
 
1-15